Concepedia

Author

Rabih Said

The University of Texas MD Anderson Cancer Center

Also Known As

R. Said, Rabih Said

56

Publications

569

Citations

12

H-Index

4

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterThe University of Texas Health Science Center at HoustonStaten Island University HospitalAmerican University of Beirut Medical CenterUniversity of California San Diego
RS

About

Rabih Said is an author at The University of Texas MD Anderson Cancer Center specializing in pathology, neuropathology, and neurology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Pathology

2

2

34

2

Medicine

1

1

16

3

Neurology

1

1

16

4

Neuropathology

1

1

16

Rabih Said

×

11

Publications

315

Citations

10

H-Index

YearCitations

P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy

Rabih Said, David S. Hong, Carla L. Warneke,

Oncotarget

2013

110

Choriocarcinoma in a 73-year-old woman: a case report and review of the literature

Nisarg Desai, Shilpi Gupta, Rabih Said,

Journal of Medical Case Reports

2010

49

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience

Nidale Tarek, Rabih Said, Clark R. Andersen,

Cancers

2020

28

Phase I Study of BIIB028, a Selective Heat Shock Protein 90 Inhibitor, in Patients with Refractory Metastatic or Locally Advanced Solid Tumors

David S. Hong, Rabih Said, Gerald S. Falchook,

Clinical Cancer Research

2013

26

Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations

Deborah Mukherji, Bassem Youssef, Christelle Dagher,

World Journal of Urology

2019

20

Clinical Challenges of Primary Diffuse Large B-Cell Lymphoma of the Dura: Case Report and Literature Review

Rabih Said, Sanaa Rizk, Qun Dai

ISRN Hematology

2011

18

Intracranial Rosai-Dorfman

Rabih Said, Francois Abi-Fadel, Jotica Talwar,

The Neurologist

2011

16

Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy

Apostolia M. Tsimberidou, Rabih Said, Kirk S. Culotta,

Clinical Epigenetics

2015

16

Characteristics and survival of patients with advanced cancer and p53 mutations

Rabih Said, Yang Ye, David S. Hong,

Oncotarget

2014

12

Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver

Rabih Said, Razelle Kurzrock, Aung Naing,

Investigational New Drugs

2015

10

Page 1